Luxura Sciences: Financial Breakdown
Decoding financial health metrics of Luxura Sciences
Total Revenue₹7.1 Cr-81%Prev. FY
Total Expenses₹6.8 Cr-83%Prev. FY
Profit After Tax₹58.8 Lakh141%Prev. FY
Total Assets₹15.0 Cr17%Prev. FY
Net Profit Margin8.3%318%Prev. FY
FAQs on Financials of Luxura Sciences
Yes. In FY25, Luxura Sciences reported a profit after tax of ₹58.3 Lakh, making it profitable.
Luxura Sciences's revenue declined 80.7% year-on-year, from ₹37.3 Cr in FY24 to ₹7.2 Cr in FY25.
Luxura Sciences's estimated EBITDA for FY25 was ₹32.1 Lakh, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY25, Luxura Sciences posted revenue of ₹7.2 Cr (down 80.7% YoY) and a profit after tax of ₹58.3 Lakh. Explore the full financials of Luxura Sciences here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links